KMID : 0338420110260020153
|
|
The Korean Journal of Internal Medicine 2011 Volume.26 No. 2 p.153 ~ p.159
|
|
Retrospective Comparison of Levofloxacin and Moxifloxacin on Multidrug-Resistant Tuberculosis Treatment Outcomes
|
|
Lee Jin-Woo
Lee Chang-Hoon Kim Deog-Kyeom Yoon Ho-Il Kim Jae-Yeol Lee Sang-Min Yang Seok-Chul Lee Jae-Ho Yoo Chul-Gyu Lee Choon-Taek Chung Hee-Soon Kim Young-Whan Han Sung-Koo Yim Jae-Joon
|
|
Abstract
|
|
|
Background/Aims: To compare the effect of levofloxacin and moxifloxacin on treatment outcomes among patients with multidrug-resistant tuberculosis (MDR-TB).
Methods: A retrospective analysis of 171 patients with MDR-TB receiving either levofloxacin or moxifloxacin was performed. Treatment responses were categorized into treatment success (cured and treatment completed) or adverse treatment outcome (death, failure, and relapsed).
Results: The median age of the patients was 42.0 years. Approximately 56% of the patients were male. Seventeen patients had extensively drug-resistant tuberculosis, and 20 had a surgical resection. A total of 123 patients (71.9%) received levofloxacin for a median 594 days, and 48 patients (28.1%) received moxifloxacin for a median 673 days. Other baseline demographic, clinical, and radiographic characteristics were similar between the two groups. The moxifloxacin group had a significantly higher number of resistant drugs (p < 0.001) and a higher incidence of resistance to ofloxacin (p = 0.005) in the drug sensitivity test. The treatment success rate was 78.9% in the levofloxacin group and 83.3% in the moxifloxacin group (p = 0.42). Adverse reactions occurred at similar rates in the groups (p = 0.44). Patients in the moxifloxacin group were not more likely to have treatment success than those in the levofloxacin group (adjusted odds ratio, 0.76; 95% confidence interval, 0.24 to 2.43; p = 0.65).
Conclusions: Both levofloxacin and moxifloxacin showed equivalent efficacy for treating MDR-TB.
|
|
KEYWORD
|
|
Levofloxacin, Moxifloxacin, Tuberculosis, multidrug-resistant, Quinolones, Tuberculosis
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|